Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elevated ADAM-like Decysin-1 (ADAMDEC1) expression is associated with increased chemo-sensitivity and improved prognosis in breast cancer patients. | Ann Transl Med | 2023 | 36760254 | PubTator, text mining | PubMed |
| Regulation of immunological tolerance by the p53-inhibitor iASPP. | Cell Death Dis | 2023 | 36746936 | PubTator, text mining | PubMed |
| High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer. | Pathol Oncol Res | 2023 | 36741965 | PubTator, text mining | PubMed |
Single-Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus-Associated (HPVA) and Non-HPVA Adenocarcinoma. | Adv Sci (Weinh) | 2023 | 36725337 | PubTator, text mining | PubMed |
| Association of SMC4 with prognosis and immune infiltration of sarcoma. | Aging (Albany NY) | 2023 | 36719264 | PubTator, text mining | PubMed |
| Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma: Current Landscape and Future Direction. | Onco Targets Ther | 2023 | 36718243 | PubTator, text mining | PubMed |
| Comprehensive analysis regarding the prognostic significance of downregulated ferroptosis-related gene AKR1C2 in gastric cancer and its underlying roles in immune response. | PLoS One | 2023 | 36701414 | PubTator, text mining | PubMed |
| Enhancing adoptive T-cell therapy with fucoidan-based IL-2 delivery microcapsules. | Bioeng Transl Med | 2023 | 36684086 | PubTator, text mining | PubMed |
| Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers. | Int J Mol Sci | 2023 | 36674809 | PubTator, text mining | PubMed |
| Multi-omics characterization of a scoring system to quantify hypoxia patterns in patients with head and neck squamous cell carcinoma. | J Transl Med | 2023 | 36627705 | PubTator, text mining | PubMed |
| ENO1 Promotes OSCC Migration and Invasion by Orchestrating IL-6 Secretion from Macrophages via a Positive Feedback Loop. | Int J Mol Sci | 2023 | 36614179 | PubTator, text mining | PubMed |
| A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer. | Nat Commun | 2023 | 36609566 | PubTator, text mining | PubMed |
| Integrative Analysis Identified CD38 As a Key Node That Correlates Highly with Immunophenotype, Chemoradiotherapy Resistance, And Prognosis of Head and Neck Cancer. | J Cancer | 2023 | 36605482 | PubTator, text mining | PubMed |
| Molecular analysis of duodenal eosinophilia. | J Allergy Clin Immunol | 2023 | 36592704 | PubTator, text mining | PubMed |
| ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment. | Oncol Rep | 2023 | 36562383 | PubTator, text mining | PubMed |
| High expression of caspase-8 as a predictive factor of poor prognosis in patients with esophageal cancer. | Cancer Med | 2023 | 36533709 | PubTator, text mining | PubMed |
| Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer. | Cancer Sci | 2023 | 36529525 | PubTator, text mining | PubMed |
| Regulatory T lymphocytes as a therapy for ischemic stroke. | Semin Immunopathol | 2023 | 36469056 | PubTator, text mining | PubMed |
| Meta-Analysis of Human Cancer Single-Cell RNA-Seq Datasets Using the IMMUcan Database. | Cancer Res | 2023 | 36459564 | PubTator, text mining | PubMed |
| CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype. | Oncogene | 2023 | 36418470 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=20